Notes
see PharmacoEconomics & Outcomes News 880 p36; 803570118
Reference
Dyer O. FDA calls for investigation into industry influence during Alzheimer's drug approval BMJ : 14 Jul 2021. Available from: URL: https://www.bmj.com/content/374/bmj.n1778
Rights and permissions
About this article
Cite this article
FDA calls for enquiry into industry influence during Alzheimer's drug approval process. PharmacoEcon Outcomes News 883, 32 (2021). https://doi.org/10.1007/s40274-021-7903-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7903-9